|
Back to Home » March 2022 News » Immunovia appoints Jeff Borcherding, previously Chief Marketing Officer at Myriad Genetics, to lead Immunovia's US business |
Immunovia appoints Jeff Borcherding, previously Chief Marketing Officer at Myriad Genetics, to lead Immunovia's US business |
March 28, 2022
LUND, Sweden, March 28, 2022 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV) has appointed Jeff Borcherding as CEO of its US subsidiary Immunovia, Inc. He joins from Myriad Genetics, one of the leading diagnostic companies in the US, where he was Chief Marketing Officer. Jeff will be...
Source URL: https://www.prnewswire.com:443/news-releases/immunovia-appoints-jeff-borcherding-previously-chief-marketing-officer-at-myriad-genetics-to-lead-immunovias-us-business-301511453.html
|
|
|
|
